Vertax Completed the A+ Round of Financing

Automotive Author: Kaiwen Li Editor: Ziying Wu Feb 22, 2023 07:36 PM (GMT+8)

Recently, Vertax announced that it had completed an additional round of financing in December last year. This round of funding will be used mainly for the R&D, manufacturing, flight test and airworthiness certification of the 2-ton eVTOL M1.

Vertax

Recently, the air travel innovation company Vertax (Chinese:御风未来) announced that it had completed an additional round of financing in December last year, led by Skyview Fund (Chinese: 天善资本). This round of funding will be used mainly for the R&D, manufacturing, flight test and airworthiness certification of M1, the 2-ton eVTOL (Electric Vertical Takeoff and Landing).

This is the second round of financing completed by Vertax within 7 months (the previous round was CNY tens of millions in May last year), with a cumulative financing amount of CNY 150 million. Compared with the previous round of financing, the first aircraft of the M1 has completed the static test and entered the final assembly stage. The first flight can be achieved in the second quarter of this year.

From the perspective of the eVTOL industry, the industry is still in a relatively early stage, but as the number of entrants gradually increases, the attention of capital is also increasing day by day. There were only 6 financing events in 2021, while there were more than 10 in 2022, and there were also several successful financing events in the first year of 2023. It is obvious that the investment wind in this field is getting stronger.

According to Xie Ling, CEO of Vertax, the eVTOL industry is still in the early stage of exploration, and each company's options for technical routes, aircraft configurations, manned or unmanned, and manned or cargoed are also different. As far as the current stage of the industry is concerned, Vertax believes that the key is to ensure sufficient safety and reduce the cost of use as much as possible, so that it is possible to realize "air travel for everyone".